STALE?Report written 28 days ago · at $17.44entry levels may be stale — re-check before acting
NNE
ค่าขนมSMALL CAP
NANO Nuclear Energy Inc. · NASDAQ · Energy / Advanced Nuclear (Micro-Reactors)
$17.44
▲ 0.81%
MCap $908.3M
Self-fetched today (no live-prices.json cache yet). Up 0.81% today, down sharply from the 52-week high ($60.87) and closer to the 52-week low ($15.44) — the stock has re-rated hard lower even as the company sits on a $577.5M cash position.
This refresh needs to be honest: NANO Nuclear's real upside no longer clears this board's 200%+ bar. The consensus target of $41.40 implies +137% from the current price — real and genuinely backed by 5-6 analysts, but well short of a clean moonshot. The company is pre-revenue but exceptionally well-capitalized ($577.5M cash after a $400M private placement), and the NRC has begun formal review of the KRONOS micro modular reactor's construction permit application — a real regulatory milestone. Near-term revenue is still years out (HALEU logistics via the Advanced Fuel Transportation subsidiary targets 2027-2028), which is exactly why this stock has fallen so far from its 52-week high even with the cash cushion. Included here as an honest carryover update, not a fresh high-conviction pick.
📝 Primary Verdict · Core Holding
SPECULATIVEค่าขนม
ค่าขนม — small position on a well-capitalized but genuinely multi-year story. Real upside has compressed below 200%; this is a carryover update, not a fresh high-conviction pick.
78
score / 100 ⓘ
⚡ Catalyst
⚛️ KRONOS NRC Construction Permit ReviewONGOING (multi-year review)
The Nuclear Regulatory Commission has initiated formal review activities for the Construction Permit Application of NANO's KRONOS micro modular reactor system — a real, dated regulatory milestone, though the full review timeline extends well beyond this year.
The company's nearest-term path to actual revenue — targeting HALEU (High-Assay Low-Enriched Uranium) logistics starting 2027-2028 through its Advanced Fuel Transportation subsidiary, well ahead of any reactor commercialization.
2027-2028
🎯 Entry Point
Entry 1
$17.44
Current price — near the 52-week low despite a very strong cash positionScale in (small)
Entry 2PREFERRED
$14.5–15.5
At/near the 52-week low zone — best R/R if SMR-sector sentiment weakens furtherIf dips
Entry 3
$11.00
Deep capitulation — only on a broad SMR-sector selloffDeep dip only
✅ Take Profit
TP1
Base — KRONOS review progresses without setbacks, SMR sentiment stabilizes
$27.03
+55%
TP2
Bull — positive regulatory milestone or a HALEU logistics contract win
Below the 52-week-low zone — thesis-neutral but a fresh low
$14
-19.7%
Hard Stop
Deep breach — would suggest a serious setback to the KRONOS review or a broad SMR-sector capitulation
$10
-42.7%
Risk / Reward
From Entry 2 ($15 mid) tight stop vs TP2
4.5 : 1
⚠ Decent R/R with a strong cash cushion, but real upside compressed below this board's usual bar — treat as a lower-conviction carryover
📅 Estimate Date
KRONOS NRC Review Progress
Multi-year regulatory process, no near-term binary decision
Ongoing
Incremental milestones, not a single dated event
📈 Possible Up % — Scenario Spread
Bear
-35%
$11.34
Base
+55%
$27.03
Bull
+95%
$34.01
Moon
+137.4%
$41.4
← downsideupside →
🏛️ Fed / Macro Risk — MEDIUM
Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution
Rate Outlook
Fed holds at 3.50–3.75%, but new Chair Warsh's hawkish tone has 9 of 18 officials projecting a further 2026 hike, with the next FOMC decision Jul 28–29, 2026.
Inflation
Core inflation remains above target and the 10-year yield sits near 4.48% — a headwind for pre-revenue growth names generally, though NNE's large cash position ($577.5M) meaningfully reduces near-term financing risk.
Sector Impact
The SMR/advanced-nuclear sector has shown real sensitivity to DOE loan-program news favoring large reactors over small modular designs this year — a structural sector headwind independent of Fed policy.
Summary
MEDIUM — NNE's exceptionally strong cash position blunts the direct financing-risk channel most pre-revenue names face, but a hawkish Jul 28-29 FOMC surprise or continued SMR-sector-wide sentiment weakness would still pressure a long-duration, multi-year story like this.
🎯 Analyst Targets
Wall Street price targets vs the current price — cross-check our TP levels
Consensus (5-6 analysts)
Strong Buy$41.4+137%
current price $17.44
🔍 Similar-Catalyst Comparable Check
Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic
NNE❌ BadH1 2026
-71%
in 180 days
Decline from 52-week high ($60.87) to current levels amid DOE large-reactor loan-program news
Same-company precedent for how sector-wide policy sentiment (not company execution) can drive a severe drawdown — directly relevant risk context for this pick.
sector✅ GoodH1 2026
+15%
in 1 day
SMR-sector reaction to DOE/NRC regulatory milestones
General sector comparable for the scale of move possible on a positive regulatory milestone, relevant to how the KRONOS NRC review could eventually move NNE.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode
Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.
⚠️
Use this stop-loss set (-20% / -25%) only when trading the earnings spot — not for the core holding (use the -19.7% / -42.7% set above). If you are holding long-term, follow the core set.
📈Pre-Catalyst Run-up Pattern
+5% to +15% same-day on positive regulatory milestonessame-day on regulatory/DOE news, not a multi-week runup
SMR/advanced-nuclear names in this cohort move on discrete DOE/NRC milestone headlines — NNE's own sharp decline from its 52-week high reflects the sector-wide DOE large-reactor-loan-program news more than any NNE-specific setback.
🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +15%
range: +5% to +25%· H1 2026 (sector pattern)
SMR-sector names have shown 5-25% pops on positive DOE/NRC regulatory milestones this cycle — Oklo's own DSA approval and NuScale's safety-system contract both triggered same-day gains as sector comparables.
❌ Catalyst Missavg -22%
range: -15% to -40%· H1 2026 (NNE)
NNE's own decline from its 52-week high ($60.87) to current levels ($17.44) — a ~71% drawdown — is the most direct same-company precedent for how far SMR-sector sentiment can turn against these names on DOE policy news unrelated to company-specific execution.
💼Spot Position Sizing
How the recommended % is derived
3%
of portfolio
Pre-revenue small-cap ($908M) with an unusually strong cash position but a genuinely multi-year commercialization timeline — 3% sizing reflects the real balance-sheet support alongside compressed near-term upside.
🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-20%($14)
Below the 52-week-low zone — thesis-neutral but a fresh low
After Catalyst (Bad Result)-25%
If the KRONOS NRC review hits a significant setback or SMR-sector sentiment deteriorates further, exit